Intelligence · Patents
Expiring patents (≤24 months)
Patent cliff watchlist — pharmaceutical patents approaching loss of exclusivity.
- Patents
- 1,230
Quick answer
1,230 pharmaceutical patents in our index expire within the next 24 months. Use year facets below for annual patent-cliff planning linked to company and drug profiles.
-
US 7217427
Polymersomes and related encapsulating membranes
granted -
US 7217541
Method of making CS6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic Escherichia coli infections
granted -
US 7217571
Gene therapy by small fragment homologous replacement
granted -
US 7217738
β2-adrenergic receptor agonists
granted -
US 7217739
Method for inducing cell death with carbonyl scavengers
granted -
US 7217795
Tumor suppressor designated TS10q23.3
granted -
US 7217808
RFRP-3 and DNA thereof
granted -
US 7217811
Human gene critical to fertility
granted -
US 7220431
Methods and compositions for applying pharmacologic agents to the ear
granted -
US 7220739
Therapeutic application of pro-apoptotic benzodiazepines
granted -
US 7220419
Self-assembling recombinant papillomavirus capsid proteins
granted -
US 7220582
Stem cells that transform to beating cardiomyocytes
granted -
US 7220726
Antifungal pimaricin compositions and therapeutic methods employing same
granted -
US 7220757
Compositions and methods for topical administration of 2-NH-heteroarylimidazoles
granted -
US 7220328
Low-smoke gas generating low order pressure pulse compositions
granted -
US 7220421
Moraxella bovis cytotoxin, cytotoxin gene, antibodies and vaccines for prevention and treatment of Moraxella bovis infections
granted -
US 7220558
Cartilage-derived morphogenetic proteins
granted -
US 7220583
Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof
granted -
US 7220719
Modulation of endogenous gene expression in cells
granted -
US 7220718
Oral treatment of hemophilia
granted -
US 7220730
Cancer specific radiolabeled conjugates regulated by the cell cycle for the treatment and diagnosis of cancer
granted -
US 7220745
Heterocyclic compounds useful to treat HCV
granted -
US 7220837
Modified vitamin K-dependent polypeptides
granted -
US 7220853
Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1
granted -
US 7220852
Coronavirus isolated from humans
granted -
US 7223406
Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
granted -
US 7223388
Modified reoviral therapy
granted -
US 7223787
Prenylation inhibitors reduce host cell permissiveness to viral replication
granted -
US 7223836
Peptides for chlamydophila pneumoniae vaccine and diagnosis
granted -
US 7223783
Indolinone derivatives
granted -
US 7223380
Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
granted -
US 7223563
Fibroblast growth factor (FGF23) nucleic acids
granted -
US 7223424
Compositions and methods for prostate and kidney health and disorders, an herbal preparation
granted -
US 7223726
Apolipoprotein A-I mutant proteins having cysteine substitutions and polynucleotides encoding same
granted -
US 7223585
Viral purification methods
granted -
US 7223571
Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
granted -
US 7223791
Function regulator for retinoid relative receptor
granted -
US 7223844
Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by Env-CD4-co-receptor complexes
granted -
US 7223853
Secreted frizzled related protein fragments
granted -
US 7223803
Polyethylene (glycol) derivatives with proximal reactive groups
granted -
US 7226589
Treatment of diseases by site specific instillation of cells or site specific transformation of cells and kits therefor
granted -
US 7226602
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
granted -
US 7226946
Substituted phenol compounds useful for anesthesia and sedation
granted -
US 7227011
Nucleic acid vaccines for prevention of flavivirus infection
granted -
US 7226588
Non-toxic mutants of pathogenic gram-negative bacteria
granted -
US 7226609
Sodium dodecyl sulfate compositions for inactivating prions
granted -
US 7226597
Mutants of Clostridium difficile toxin B and methods of use
granted -
US 7226920
Aminotriazole compounds useful as inhibitors of protein kinases
granted
Frequently asked questions
What is a patent cliff?
A patent cliff is when key pharmaceutical patents expire, opening markets to generics or biosimilars. This hub lists USPTO patents with approaching expiration dates.
Are expiration dates estimates?
Expiration dates derive from USPTO PatentsView grant dates and term estimates. Confirm with Orange Book, patent counsel, and USPTO records before investment decisions.